- Early vs. delayed QTc prolongation in acute poisoning: A prognostic accuracy study-A case series
- Uncovering possible silent acquired long QT syndrome using exercise stress testing in long-term pediatric acute lymphoblastic leukemia survivors
- A case report of a combined implantation technique of a cardioverter-defibrillator in an infant with long QT syndrome type 8 (Timothy's syndrome)
- Peripartum management of cardiac arrhythmias: a narrative review
- Roles of Atrial Arrhythmias in Triggering Torsade de Pointes in Patients With Acquired Long-QT Syndrome
- Congenital Long QT Syndrome Unmasked by Albuterol in an Adolescent with Asthma
- Does IV fentanyl, frequently used in emergency departments, change QTC value? A prospective observational study
- Idiopathic Ventricular Fibrillation - Just How Much Idiopathic is it?
- Does IV fentanyl, frequently used in emergency departments, change QTC value? A prospective observational study
- Does IV fentanyl, frequently used in emergency departments, change QTC value? A prospective observational study
- Relevance of accurate QT correction in the assessment of long QT syndrome
- Does IV fentanyl, frequently used in emergency departments, change QTC value? A prospective observational study
- Does IV fentanyl, frequently used in emergency departments, change QTC value? A prospective observational study
- Does IV fentanyl, frequently used in emergency departments, change QTC value? A prospective observational study
- Does IV fentanyl, frequently used in emergency departments, change QTC value? A prospective observational study
- Efficacy of prescribing Inderal for polymorphic ventricular tachycardia in a young patient with the normal QT interval: A case report study
- Low foetal heart rate, a potentially ominous finding: case report
- Long QT Syndrome With Drugs Used in the Management of Arrhythmias: A Systematic Review
- QTc Interval Prolongation as an Adverse Event of Azole Antifungal Drugs: Case Report and Literature Review
- Prescribing Practices of QT Interval Prolonging Drugs in Critically Ill Older Adults in South India
- Detection of distant relatedness in biobanks to identify undiagnosed cases of Mendelian disease as applied to Long QT syndrome
- Computational insights into the mechanisms underlying structural destabilization and recovery in trafficking-deficient hERG mutants
- Knock-in swine model reveals new arrhythmia mechanism in Timothy syndrome
- A case of intellectual disability with long QT syndrome by NAA10 gene variation
- Multimodal fusion learning for long QT syndrome pathogenic genotypes in a racially diverse population
- Targeting the IKs Channel PKA Phosphorylation Axis to Restore Its Function in High-Risk LQT1 Variants
- Targeting the IKs Channel PKA Phosphorylation Axis to Restore Its Function in High-Risk LQT1 Variants
- Targeting the IKs Channel PKA Phosphorylation Axis to Restore Its Function in High-Risk LQT1 Variants
- Targeting the IKs Channel PKA Phosphorylation Axis to Restore Its Function in High-Risk LQT1 Variants
- Targeting the IKs Channel PKA Phosphorylation Axis to Restore Its Function in High-Risk LQT1 Variants
- Targeting the IKs Channel PKA Phosphorylation Axis to Restore Its Function in High-Risk LQT1 Variants
- Targeting the IKs Channel PKA Phosphorylation Axis to Restore Its Function in High-Risk LQT1 Variants
- Targeting the IKs Channel PKA Phosphorylation Axis to Restore Its Function in High-Risk LQT1 Variants
- Targeting the IKs Channel PKA Phosphorylation Axis to Restore Its Function in High-Risk LQT1 Variants
- Targeting the IKs Channel PKA Phosphorylation Axis to Restore Its Function in High-Risk LQT1 Variants
- Targeting the IKs Channel PKA Phosphorylation Axis to Restore Its Function in High-Risk LQT1 Variants
- Targeting the IKs Channel PKA Phosphorylation Axis to Restore Its Function in High-Risk LQT1 Variants
- Drug-induced long QT syndrome: Concept and non-clinical models for predicting the onset of drug-induced torsade de pointes in patients in compliance with ICH E14/S7B guidance
- Targeting the IKs Channel PKA Phosphorylation Axis to Restore Its Function in High-Risk LQT1 Variants
- Targeting the IKs Channel PKA Phosphorylation Axis to Restore Its Function in High-Risk LQT1 Variants
- Targeting the IKs Channel PKA Phosphorylation Axis to Restore Its Function in High-Risk LQT1 Variants
- Targeting the IKs Channel PKA Phosphorylation Axis to Restore Its Function in High-Risk LQT1 Variants
- Targeting the IKs Channel PKA Phosphorylation Axis to Restore Its Function in High-Risk LQT1 Variants
- Targeting the IKs Channel PKA Phosphorylation Axis to Restore Its Function in High-Risk LQT1 Variants
- Targeting the IKs Channel PKA Phosphorylation Axis to Restore Its Function in High-Risk LQT1 Variants
- Targeting the IKs Channel PKA Phosphorylation Axis to Restore Its Function in High-Risk LQT1 Variants
- Targeting the IKs Channel PKA Phosphorylation Axis to Restore Its Function in High-Risk LQT1 Variants
- Antisense Oligonucleotide Therapy for Calmodulinopathy
- Substrate modification via epicardial ablation in a patient with long QT syndrome type II
- Inappropriate ventricular pacing-induced ventricular fibrillation in a long QT type 3 syndrome patient with implantable cardioverter-defibrillator